News
INITIO updates and comments on new studies
New Prostate Cancer Drug Canada
Article: https://globalnews.ca/news/9178252/new-prostate-cancer-drug-canada/ ‘Very exciting treatment’: New advanced prostate cancer drug available in Canada WATCH: For patients with advanced metastatic prostate cancer, there have been few treatment
Health Canada Approves Illuccix® for Prostate Cancer Imaging
Article: https://telixpharma.com/news-views/health-canada-approves-illuccix-for-prostate-cancer-imaging/ Health Canada Approves Illuccix® for Prostate Cancer Imaging Telix announces that Health Canada has approved Illuccix® [kit for the preparation of gallium (68Ga) gozetotide
PET reveals visual brain pattern of long COVID
A PET study in 143 individuals has identified the metabolic fingerprint of long COVID in the brain, involving decreased activity in the olfactory and limbic areas, and the pons and cerebellum.
PET predicts long term response after CAR-T treatment for lymphoma
In the study of CAR-T with lymphoma, researchers are discovering that PET scans with FDG (a modified sugar molecule) predict long term response to CAR-T therapy. For patients who are not responding, this gives doctors time to switch to other treatment regimens without having to wait.
FDG and NaF PET/CT Predictive for Overall Survival in Genitourinary Malignancies
…The second generation Discovery PET/CT scanner at INITIO includes the ability to calculate the metabolic volume of a tumor, and we routinely report these emerging biomarkers to our referring physicians….
PET tracer may improve understanding of Alzheimer’s Disease
This new PET tracer compound, SMBT-1, focuses on astrocytes, which are the most abundant cell type in the brain, even more abundant than neurons. The tracer is able to selectively detect activated astrocytes, which may be a marker of undesirable brain inflammation which precedes cognitive deterioration.
